000020 — Dongwha Pharm Co Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩235bn
- KR₩231bn
- KR₩361bn
- 62
- 64
- 52
- 66
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 9,394 | 28,715 | 19,583 | 21,591 | 28,237 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 12,529 | 4,028 | 16,235 | 19,006 | 914 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -20,123 | 8,778 | -11,880 | -23,886 | -13,880 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 13,285 | 52,228 | 36,031 | 29,221 | 29,167 |
Capital Expenditures | -5,506 | -30,115 | -24,774 | -20,091 | -26,346 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -5,673 | 4,284 | -640 | -23,181 | 29,209 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -11,178 | -25,831 | -25,414 | -43,272 | 2,863 |
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -4,938 | -5,458 | -8,783 | -12,013 | 5,866 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -2,835 | 20,817 | 1,883 | -26,133 | 37,970 |